 |
|
Anticoagulation Therapy in Pediatric Patients With Sinovenous Thrombosis
A Cohort Study
Gabrielle deVeber, MD;
Anthony Chan, MBBS;
Paul Monagle, MBBS;
Velma Marzinotto, BScN;
Derek Armstrong, MD;
Patricia Massicotte, MD;
Michael Leaker, MD;
Maureen Andrew, MD
Arch Neurol. 1998;55:1533-1537.
Objective To assess the use of anticoagulant therapy in a consecutive cohort study of children with sinovenous thrombosis (SVT).
Methods A single institutional pilot study of anticoagulant therapy was conducted from January 1992 to December 1996 at the Hospital for Sick Children, Toronto, Ontario. Consecutive children with the diagnosis of SVT, made by computed tomography, magnetic resonance imaging (MRI), MRI with venography, ultrasonography, nuclear brain scanning, or conventional angiography were eligible for anticoagulant therapy.
Radiographic Evaluation Most children underwent multiple radiographic tests for evaluation of the central nervous system. Of the 32 episodes of SVT, CT was performed in 30, MRI with or without venography in 26, ultrasonography in 11, and nuclear brain scanning in 5. The majority of the SVTs were located at the superior sagittal sinus (50%) and right lateral sinus complex (44%).
Results There were 30 consecutive children with 32 episodes of SVT during the 5-year study (2 girls had recurrent SVT). The median age was 6.2 years (age range, 3 days to 18 years), and the sex of the patients was evenly distributed (15 girls and 15 boys). The primary associated clinical conditions consisted of systemic lupus erythematosus (n=5), renal disease (n=3), perinatal distress (n=2), congenital heart disease (n=1), cerebral arteriovenous malformation (n=1), and neurosurgery for refractory seizures (n=1). The remainder were previously healthy children older than 1 month (n=10) and newborns (n=7). Eight children were ineligible for anticoagulant therapy because of an associated intracranial hemorrhage (n=6), a postoperative bleeding risk after neurosurgery (n=1), or a prolonged delay from the diagnosis to the time of referral (n=1). Ten children received standard heparin, and 12 children received low-molecular-weight heparin (LMWH) (enoxaparin sodium). Eighteen children were treated with oral anticoagulants for 3 months after initial heparin therapy, and 4 patients received LMWH for the entire course of treatment. There was no intracranial hemorrhage in the 12 patients treated with LMWH, but there was 1 case of clinically silent bleeding in the standard heparin group.
Conclusions The results of this pilot study suggest that anticoagulant therapy, in particular LMWH, is safe and may have a role in the treatment of children with SVT. A randomized controlled trial is warranted.
From the Department of Pediatrics, McMaster University, Hamilton, Ontario (Drs deVeber, Chan, and Andrew), and the Divisions of Hematology (Drs Monagle, Massicotte, Leaker, and Andrew and Ms Marzinotto), Neurology (Dr deVeber), and Neuroradiology (Dr Armstrong), Hospital for Sick Children, Toronto, Ontario.
RELATED ARTICLE
Prothrombotic Disorders in Infants and Children With Cerebral Thromboembolism
Gabrielle deVeber, Paul Monagle, Anthony Chan, Daune MacGregor, Rosalind Curtis, Sharon Lee, Patricia Vegh, Margaret Adams, Velma Marzinotto, Michael Leaker, M. Patricia Massicotte, David Lillicrap, and Maureen Andrew
Arch Neurol. 1998;55(12):1539-1543.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young
Roach et al.
Stroke 2008;39:2644-2691.
ABSTRACT
| FULL TEXT
Cerebral Venous Sinus Thrombosis in Children: A Multicenter Cohort From the United States
Wasay et al.
J Child Neurol 2008;23:26-31.
ABSTRACT
Human Infection with Fusobacterium necrophorum (Necrobacillosis), with a Focus on Lemierre's Syndrome
Riordan
Clin. Microbiol. Rev. 2007;20:622-659.
ABSTRACT
| FULL TEXT
Papilloedema secondary to otitic hydrocephalus
Vagefi and Fredrick
Br. J. Ophthalmol. 2006;90:646-646.
FULL TEXT
Cerebral sinovenous thrombosis in the neonate.
Fitzgerald et al.
Arch Neurol 2006;63:405-409.
ABSTRACT
| FULL TEXT
Summary proceedings from the neurology group on neonatal seizures.
Clancy
Pediatrics 2006;117:S23-S27.
ABSTRACT
| FULL TEXT
Urgent Clinical Challenges in Children With Ischemic Stroke: Analysis of 1065 Patients From the 1-800-NOCLOTS Pediatric Stroke Telephone Consultation Service
Kuhle et al.
Stroke 2006;37:116-122.
ABSTRACT
| FULL TEXT
Short-Term Intellectual Outcome After Arterial Ischemic Stroke and Sinovenous Thrombosis in Childhood and Infancy
Hetherington et al.
J Child Neurol 2005;20:553-559.
ABSTRACT
Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome
Sebire et al.
Brain 2005;128:477-489.
ABSTRACT
| FULL TEXT
Cerebral Sinovenous Thrombosis in Children: Another Reason to Treat Iron Deficiency Anemia
Benedict et al.
J Child Neurol 2004;19:526-531.
ABSTRACT
Anti-Xa Stability of Diluted Enoxaparin for Use in Pediatrics
Dager et al.
The Annals of Pharmacotherapy 2004;38:569-573.
ABSTRACT
| FULL TEXT
A 12-year-old girl with pharyngitis, meningitis and sinovenous thrombosis
Jaremko et al.
CMAJ 2003;169:811-812.
FULL TEXT
Anticoagulation Therapy in Cerebral Sinovenous Thrombosis and Ulcerative Colitis in Children
Kao et al.
J Child Neurol 2002;17:479-482.
ABSTRACT
Nonrandomized Comparison of Local Urokinase Thrombolysis Versus Systemic Heparin Anticoagulation for Superior Sagittal Sinus Thrombosis Editorial Comment
Wasay et al.
Stroke 2001;32:2310-2317.
ABSTRACT
| FULL TEXT
Cerebral Venous Thrombosis in Children
Carvalho et al.
J Child Neurol 2001;16:574-580.
ABSTRACT
Isolated intracranial hypertension as the only sign of cerebral venous thrombosis
Biousse et al.
Neurology 1999;53:1537-1537.
ABSTRACT
| FULL TEXT
Stroke in childhood
Kirkham
Arch. Dis. Child. 1999;81:85-89.
FULL TEXT
|
